| Trial ID: | L0117 |
| Source ID: | NCT04175392
|
| Associated Drug: |
Probiotic
|
| Title: |
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
|
| Acronym: |
PRONE
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver Disease|Fibrosis, Liver|Cirrhosis, Liver|Steatohepatitis, Nonalcoholic
|
| Interventions: |
Drug: Align Probiotic Supplement Capsule|Drug: Placebos
|
| Outcome Measures: |
Probiotic effects on liver fibrosis|Probiotic effects on Liver enzymes, AST|Probiotic effects on Liver enzymes, ALT|Probiotic effects on Diabetic Markers|Probiotic effects on BMI|Probiotic effects on LDL
|
| Sponsor/Collaborators: |
William Beaumont Hospitals
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
80
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
January 12, 2021
|
| Completion Date: |
May 30, 2023
|
| Results First Posted: |
--
|
| Last Update Posted: |
November 24, 2021
|
| Locations: |
Beaumont Hospital, Farmington Hills, Michigan, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT04175392
|
